InsidersTradesSigma
환인제약: insider trades · South Korea · DART (FSS)
DART:company-f80558KR·DART (FSS)Mcap 171.1Bn€Healthcare
Discover the full directors' dealings record of 환인제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 환인제약 has published 4 reports. Market capitalisation: €171.1bn. The latest transaction was disclosed on 11 May 2026 (Other). Among the most active insiders: 피델리티매니지먼트앤리서치컴퍼니엘엘씨. All data is openly available.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
11210.00 €
Analyst consensus
1 analysts17000.00 €Target 17000.00 €(+52%)17000.00 €
Income statement
Revenue255.21 Bn€
Gross profit87.10 Bn€34% margin
Net income13.60 Bn€5.3% margin
Valuation
PER (forward)8.9x
Beta0.26
Balance sheet & cash
Market cap171.14 Bn€
Total debt679.0 M€
Free Cash Flow2.86 Bn€
Debt / Equity0%
Profitability & ownership
ROE3.4%
ROA1.8%
% insiders23.3%
% institutions12.4%
Last declaration on 11 May 2026
Declarations4 total
4 of 4 declarations